Agenus | AGEN - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
AbbVie USD 12.54B 474M 2026-03
Agenus USD 34.2M 4.61M 2025-12
Amgen USD 6.89B 415M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Celldex Therapeutics USD 121K 609K 2025-12
CSL USD 4.46B 2.71B 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Gilead Sciences USD 5.52B 791M 2026-03
GlaxoSmithKline GBP 5.75B 429M 2026-03
Glaxosmithkline GBP 5.75B 2.99B 2026-03
Incyte USD 1.17B 217.51M 2026-03
Intrexon USD -297K 167K 2024-06
J&J USD 18.55B 1.31B 2026-06
Jiangsu Hengrui CNY 7.27B 918.27M 2025-12
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
MacroGenics USD 11.24M 19.87M 2026-03
Merck EUR 3.07B 104M 2026-03
Merck USD 10.85B 2.57B 2025-12
Novartis USD 10.07B 184M 2026-03
Novavax USD 125.04M 76.09M 2025-12
Pfizer USD 11.04B 1.24B 2026-03
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Veracyte USD 101.16M 814K 2026-03